“Obesity paradoxes”: main causes of an “inverse” cardiovascular epidemiology
https://doi.org/10.15829/1728-8800-2018-5-92-98
Abstract
Taken the continuous increase of obesity prevalence, most countries in the world deal with an epidemy, one of the main healthcare concerns. In the structure of nosology associated with overweight and obesity, cardiovascular is leading. Also, in the recent trials and meta analyses there is negative correlation found for body mass index and clinical outcomes characterizing better survival and lower events rate in those with higher BMI, as less chronic diseases. Such facts facilitated a number of discussions on the predictive value of overweight and obesity and consideration whether to correct those in cardiovascular patients as secondary prevention. Current article is focused on the main causes for an “inverse” cardiovascular epidemiology in overweight and obesity.
About the Authors
M. A. Druzhilov
Medical and Sanitary Institution of the FSS in Karelia Republic
Russian Federation
Russian Federation
Petrozavodsk
Т. Yu. Kuznetsova
Petrozavodsk State University
Russian Federation
Russian Federation
О. Yu. Druzhilova
Petrozavodsk State University
Russian Federation
Russian Federation
References
1. Shlyakhto EV, Nedogoda SV, Konradi AO, et al. The concept of novel national clinical guidelines on obesity. Russ J Cardiol 2016; 4: 7-13. (In Russ.) DOI: 10.15829/1560-4071-2016-4-7-13.
2. Muromtseva GA, Kontsevaya AV, Konstantinov VV, et al. The prevalence of noninfectious diseases risk factors in Russian population in 2012-2013 years. The results of ECVD-RF. Cardiovascular Therapy and Prevention 2014; 13 (6): 4-11. (In Russ.) DOI: 10.15829/1728-8800-2014-6-4-11.
3. Marie N, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384:766-81. DOI: 10.1016/S0140-6736(14)60460-8.
4. Lim S, Vos T, Flaxman A, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 19902010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380 (9859): 2224-60. DOI: 10.1016/S0140-6736(12)61766-8.
5. The GBD 2015 Obesity Collaborators. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med 2017; 377: 13-27. DOI: 10.1056/NEJMoa1614362.
6. Stewart S, Cutler D, Rosen A. Forecasting the effects of obesity and smoking on U.S. life expectancy. N Engl J Med 2009; 361: 2252-60. DOI: 10.1056/NEJMsa0900459.
7. Whitlock G, Lewington S, Sherliker P. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083-96. DOI: 10.1016/S0140-6736(09)60318-4.
8. The Global BMI Mortality Collaboration. Body-mass index and all-cause mortality: individual participant-data meta-analysis of 239 prospective studies in four continents. Lancet 2016; 388: 776-86. DOI: 10.1016/S0140-6736(16)30175-1.
9. Aune D, Sen A, Prasad M, et al. BMI and all cause mortality: systematic review and non-linear dose-response metaanalysis of 230 cohort studies with 3,74 million deaths among 30,3 million participants. BMJ 2016; 353:i2156. DOI: 10.1136/bmj.i2156.
10. Collins G, Altman D. Predicting the 10-year risk of cardiovascular disease in the United Kingdom: independent and external valida-tion of an updated version of QRISK2. BMJ 2012; 344: e4181. DOI: 10.1136/bmj.e4181.
11. Piepoli М, Hoes А, Agewall S, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2016). Eur Heart J 2016; 37 (29): 2315-81. DOI: 10.1016/j.atherosclerosis.2016.05.037.
12. Hainer V, Aldhoon-Hainerov I. Obesity Paradox Does Exist. Diabetes Care 2013; 36 (2): 276-81. DOI: 10.2337/dcS13-2023.
13. Antonopoulos A, Tousoulis D. The molecular mechanisms of obesity paradox. Cardiovascular Research 2017; 113: 1074-86. DOI: 10.1093/cvr/cvx106.
14. . Padwal R, McAlister F, McMurray J, et al. Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes (Lond) 2014; 38 (8): 1110-4. DOI: 10.1038/ijo.2013.203.
15. Doehner W, Haehling S, Anker S. Protective overweight in cardiovascular disease: moving from 'paradox' to 'paradigm. Eur Heart J 2015; 36: 2729-32. DOI: 101093/ eurheartj/ehv414.
16. Samocha-Bonet D, Dixit V, Kahn C, et al. Metabolically healthy and unhealthy obese: the 2013 Stock Conference report. Obes Rev 2014; 15: 697-708. DOI: 101111/obr.12199.
17. Ortega F, Lavie C, Blair S. Obesity and Cardiovascular Disease. Circ Res 2016; 118: 1752-70. DOI: 101161/CIRCRESAHA115.306883.
18. Badrick E, Sperrin M, Buchan I, et al. Obesity paradox and mortality in adults with and without incident type 2 diabetes: a matched population-level cohort study. BMJ Open Diabetes Research and Care 2017; 5: e000369. DOI: 101136/bmjdrc-2016-000369.
19. Abdullah A, Wolfe R, Stoelwinder J, et al. The number of years lived with obesity and the risk of all-cause and cause-specific mortality. Int J Epidemiol 2011; 40 (4): 98596. DOI: 101093/ije/dyr018.
20. Barry V, Baruth M, Beets M, et al. Fitness vs. fatness on all-cause mortality: a metaanalysis. Prog Cardiovasc Dis 2014; 56: 382-90. DOI: 101016/j.pcad.2013.09.002.
21. Hansel B, Roussel R, Elbez Y, et al. Cardiovascular risk in relation to body mass index and use of evidence-based preventive medications in patients with or at risk of atherothrombosis. Eur Heart J 2015; 36: 2716-28. DOI: 10.1093/eurheartj/ehv347.
22. Shah R, Abbasi S, Yamal J, et al. Impaired fasting glucose and body mass index as determinants of mortality in ALLHAT: is the obesity paradox real? J Clin Hypertens (Greenwich) 2014; 16: 451-8. DOI: 10.1111/jch.12325.
23. Flegal K, Kit B, Orpana H, et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories. JAMA 2013; 309 (1): 71-82. DOI: 10.1001/jama.2012.113905.
24. Nuttall F. Body mass index: obesity, BMI, and health: a critical review. Nutr Today 2015; 50: 117-28. DOI: 10.1097/NT.0000000000000092.
25. Ponce J, De Maria E, Nguyen N, et al. American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in 2015 and surgeon workforce in the United States. Surgery for Obesity and Related Diseases 2016; 12: 1637-9. DOI: 10.1016/j.soard.2016.08.488.
26. Gomez-Ambrosi J, Silva C, Galofre J, et al. Body adiposity and type 2 diabetes: increased risk with a high body fat percentage even having a normal BMI. Obesity (Silver Spring) 2011; 19 (7):1439-44. DOI: 10.1038/oby.2011.36.
27. De Schutter A, Lavie C, Arce K, et al. Correlation and discrepancies between obesity by body mass index and body fat in patients with coronary heart disease. J Cardiopulm Rehabil Prev 2013; 33 (2): 77-83. DOI: 101097/HCR.0b013e31828254fc.
28. Oliverosa E, Somersa V, Sochor O, et al. The Concept of Normal Weight Obesity. Progress in Cardiovascular Diseases 2014; 56 (4): 426-33. DOI: 101016/j.pcad.2013.10.003.
29. Franco L, Morais C, Cominetti C. Normal-weight obesity syndrome: diagnosis, prevalence, and clinical implications. Nutrition Reviews 2016; 74 (9): 558-70. DOI: 10.1093/nutrit/nuw019.
30. Atkins J, Whincup P, Morris R, et al. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc 2014; 62: 253-60. DOI: 10.1111/jgs.12652.
31. Lavie C, De Schutter A, Patel D, et al. Body composition and survival in stable coronary heart disease: impact of lean mass index and body fat in the 'obesity paradox. JACC 2012; 60: 1374-80. DOI: 10.1016/j.jacc.2012.05.037.
32. Tian S, Xu Y. Association of sarcopenic obesity with the risk of all-cause mortality: a meta-analysis of prospective cohort studies. Geriatr Gerontol Int 2016; 16 (2):155-66. DOI: 10.1111/ggi.12579.
33. Carbone S, Buckley L, Trankle C, et al. Obesity and heart failure: can nutritional status explain the paradoxical relationship? EC Cardiol 2015; 2 (2): 94-8.
34. Padwal R, Leslie W, Lix L, et al. Relationship among body fat percentage, body mass index, and all-cause mortality: a cohort study. Ann Intern Med 2016; 164: 532-41. DOI: 10.7326/M15-1181.
35. Druzhilov MA, Druzhilova OYu, Kuznetsova TYu, et al. Obesity as cardiovascular risk factor: accent on quality and functional activity of adipose tissue. Russ J Cardiol 2015; (4): 111-7. (In Russ.) DOI: 10.15829/1560-4071-2015-4-111-117.
36. Hocking S, Samocha-Bonet D, Milner K, et al. Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots. Endocr Rev 2013; 34: 463-500. DOI: 10.1210/er.2012-1041.
37. Sun K, Kusminski C, Scherer P. Adipose tissue remodeling and obesity. J Clin Invest 2011; 121 (6): 2094-101. DOI: 10.1172/JCI45887.
38. Coutinho T, Goel K, Correa de Sa D, et al. Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. JACC 2011; 57 (19): 1877-86. DOI: 10.1016/j.jacc.2010.11.058.
39. Amato M. Cut-off points of the visceral adiposity index identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids Health Dis 2011; 10 (183): 1-8. DOI: 10.1186/1476-511X-10-183.
40. Despres J. Body Fat Distribution and Risk of Cardiovascular Disease: An Update. Circulation 2012; 126: 1301-13. DOI: 10.1161/CIRCULATIONAHA.111.067264.
41. Lee J, Pedley A, Hoffmann U, et al. Association of Changes in Abdominal Fat Quantity and Quality With Incident Cardiovascular Disease Risk Factors. JACC 2016; 68 (14): 1509-21. DOI: 10.1016/j.jacc.2016.06.067.
42. Mauad F, Chagas-Neto F, Benedeti A, et al. Reproducibility of abdominal fat assessment by ultrasound and computed tomography. Radiol Bras 2017; 50 (3): 1417. DOI: 10.1590/0100-3984.2016.0023.
43. Kuznetsova TYu, Chumakova GA, Druzhilov MA, et al. Clinical application of quantitative echocardiographic assessment of epicardial fat tissue in obesity. Russ J Cardiol 2017; (4): 81-7. (In Russ.)DOI: 10.15829/1560-4071-2017-4-81-87.
44. Morelli M, Gaggini M, Daniele G, et al. Ectopic fat: the true culprit linking obesity and cardiovascular disease? Thromb Haemost 2013; 110: 651-60. DOI: 10.1160/TH13-04-0285.
45. Chun-Yuan Chu C, Lee W, Hsu P, et al. Association of Increased Epicardial Adipose Tissue Thickness With Adverse Cardiovascular Outcomes in Patients With Atrial Fibrillation. Medicine 2016; 95 (11): e2874. DOI: 10.1097/MD.0000000000002874.
Review
For citations:
Druzhilov M.A., Kuznetsova Т.Yu., Druzhilova О.Yu. “Obesity paradoxes”: main causes of an “inverse” cardiovascular epidemiology. Cardiovascular Therapy and Prevention. 2018;17(5):92-98. (In Russ.) https://doi.org/10.15829/1728-8800-2018-5-92-98
Views:
1349
Email this article 
